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Diving Deeper into 
Acne Lesions
Our understanding of the 
pathological processes of acne is 
incomplete even though acne is 
the most common inflammatory 
skin disorder. CD4+ T cells have 
been identified previously in 
acne lesions, and Kistowska 
and colleagues recently 
demonstrated that these cells 
exhibit a T helper type 17 
(Th17) and Th17/Th1 cytokine 
profile and that T cells specific 
for Propionibacterium acnes, a 
contributing agent, are present 
in the peripheral blood of 
acne patients. Moreover, these 
authors proposed that targeting 
of effector (IL-17 or IFN-γ) or 
differentiation (IL-1β or IL-23) 
cytokines may be useful in 
treating acne. See page 110
The Split Personality 
of Basophils
UVB irradiation is used widely 
to treat skin disorders, and 
at low doses such radiation 
induces immune suppression 
mediated by regulatory T 
cells (Tregs). In line with the 
fact that Tregs are dependent 
on the epidermal growth 
factor–like amphiregulin 
(AREG) for optimal function, 
Meulenbroeks and colleagues 
reported that UVB-induced 
immunosuppression of 
contact hypersensitivity is 
AREG-dependent and that this 
AREG is actually produced by 
basophils and not mast cells, 
which were the anticipated 
source. These findings suggest a 
dual functionality for basophils 
in initiating type 2 immune 
responses and enhancing 
suppressive Treg function.  
See page 222
Malignant T Cells Break the Barrier
Epithelial hyperproliferation characterizes the early stages of 
cutaneous T-cell lymphomas (CTCLs), although CTCL patients 
often die as a result of bacterial infections, implicating a barrier 
defect in the diseased skin. Using an organotypic culture sys-
tem, Thode and colleagues demonstrated that malignant T cells 
alter keratinocyte behavior, growth, and function via secretion 
of considerable levels of the carbohydrates galectin-1 and -3, 
which promote cell differentiation, activate signaling pathways 
(STAT and MAPK), and contribute to inflammatory diseases. These malignant T cells also 
drive downregulation of key barrier proteins in keratinocytes, leading to loosely packed 
desmosomes and increased epithelial permeability. These findings provide mechanistic 
insight into the relationship between hyperproliferation and defective barrier function in 
CTCL. See page 238
Suppression of Signaling
To probe the function of activator 
protein 1 (AP1) signaling, Rorke and 
colleagues examined the effects of 
suppression of this transcription fac-
tor in the epidermis. Interestingly, 
suprabasal epidermal expression 
of a dominant-negative c-jun form 
that inhibits AP1 function resulted 
in a phenotype that features the 
key hallmarks of keratodermas: 
epidermal thickening, hyperplasia, 
and hyperkeratosis. This pheno-
type was observed in the absence 
of gene mutations that are known 
to underlie this disease, indicating that AP1 suppression is sufficient to cause the phe-
notype. These findings suggested that altered AP1 signaling may occur in inherited 
keratodermas and may also be involved in acquired keratodermas in response to 
environmental factors. See page 170 
Traffic Pattern
Chalupa and colleagues demonstrated that the 
carbohydrate-binding protein galectin-3 is expressed 
in melanocytes and localizes in the cell body periph-
eral to the Golgi zone, placing this protein in the 
perfect position to function in the trafficking of mela-
nosome-destined cargo from the Golgi to the pre-
melanosome. In agreement with such a function, 
galectin-3 colocalized with tyrosinase and tyrosinase-
related protein-1, which are crucial in melanogenesis. 
Furthermore, downregulation of galectin-3 resulted in 
diminished melanin synthesis. Together, these results 
highlight galectin-3 as a component that regulates melanin biosynthesis via regulation of 
melanosome-destined cargo trafficking. See page 202 
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